Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16718462rdf:typepubmed:Citationlld:pubmed
pubmed-article:16718462lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C0030281lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C0282587lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C0060369lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C1332656lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C0023688lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C1710082lld:lifeskim
pubmed-article:16718462lifeskim:mentionsumls-concept:C2826008lld:lifeskim
pubmed-article:16718462pubmed:issue8lld:pubmed
pubmed-article:16718462pubmed:dateCreated2006-7-10lld:pubmed
pubmed-article:16718462pubmed:abstractTextIL-1beta released from immune cells induces beta cell pro-apoptotic signalling via mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-kappaB). In neurons, the neural cell adhesion molecule (NCAM) signals to several elements involved in IL-1beta-induced pro-apoptotic signalling in beta cells. Pancreatic beta cells express NCAM, but its biological effects in these cells are unclear. The aim of this study was to investigate whether there is cross-talk between NCAM signalling and cytokine-induced pro-apoptotic signalling.lld:pubmed
pubmed-article:16718462pubmed:languageenglld:pubmed
pubmed-article:16718462pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:citationSubsetIMlld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16718462pubmed:statusMEDLINElld:pubmed
pubmed-article:16718462pubmed:monthAuglld:pubmed
pubmed-article:16718462pubmed:issn0012-186Xlld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:LUGGlld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:BockEElld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:BillestrupNNlld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:Mandrup-Pouls...lld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:PetersenL GLGlld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:BerezinVVlld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:SaldeenJJlld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:StørlingJJlld:pubmed
pubmed-article:16718462pubmed:authorpubmed-author:HedingPPlld:pubmed
pubmed-article:16718462pubmed:issnTypePrintlld:pubmed
pubmed-article:16718462pubmed:volume49lld:pubmed
pubmed-article:16718462pubmed:ownerNLMlld:pubmed
pubmed-article:16718462pubmed:authorsCompleteYlld:pubmed
pubmed-article:16718462pubmed:pagination1864-75lld:pubmed
pubmed-article:16718462pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:meshHeadingpubmed-meshheading:16718462...lld:pubmed
pubmed-article:16718462pubmed:year2006lld:pubmed
pubmed-article:16718462pubmed:articleTitleIL-1beta-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line.lld:pubmed
pubmed-article:16718462pubmed:affiliationSteno Diabetes Center, Niels Steensens Vej 2, 2820 Gentofte, Denmark.lld:pubmed
pubmed-article:16718462pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16718462pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16718462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16718462lld:pubmed